-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2023 to Q3 2024.
- BioXcel Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -3.37K %.
- BioXcel Therapeutics, Inc. annual Operating Margin for 2023 was -12.4K %, a 70.8% increase from 2022.
Operating Margin, Quarterly (%)